Capital International Investors 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 12:25 pm Sale |
2024-02-12 | 13G | Karuna Therapeutics, Inc. KRTX |
Capital International Investors | 448,866 1.200% |
-3,865,518 (-89.60%) |
Filing |
| 2024-02-09 5:19 pm Purchase |
2024-02-07 | 13G | Karuna Therapeutics, Inc. KRTX |
Capital International Investors | 4,314,384 11.400% |
475,644 (+12.39%) |
Filing |
| 2023-06-09 3:48 pm Purchase |
2023-06-12 | 13G | Karuna Therapeutics, Inc. KRTX |
Capital International Investors | 3,838,740 10.300% |
3,838,740 (New Position) |
Filing |